As COL11A1 tends to accumulate in tumor tissues and promote malignant progression of human cancer, with lower expression levels in normal tissues, targeting COL11A1 has become an attractive strategy for the treatment of various cancers. The gene discussed is COL11A1; the disease is cancer.